作者
Javed Butler,W. Schuyler Jones,Jacob A. Udell,Stefan D. Anker,Mark C. Petrie,Josephine Harrington,Michaela Mattheus,Isabella Zwiener,Offer Amir,M. Cecilia Bahit,Johann Bauersachs,Antoni Bayés‐Genís,Yundai Chen,Vijay Chopra,Gemma A. Figtree,Junbo Ge,Shaun G. Goodman,Nina Gotcheva,Shinya Goto,Tomasz Gąsior,Waheed Jamal,James L. Januzzi,Myung Ho Jeong,Yuri Lopatin,Renato D. Lópes,Béla Merkely,Puja B. Parikh,Alexander Parkhomenko,Piotr Ponikowski,Xavier Rosselló,Morten Schou,Dušica Simić,Philippe Gabríel Steg,Joanna Szachniewicz,Peter van der Meer,Dragoş Vinereanu,Shelley Zieroth,Martina Brueckmann,Mikhail Sumin,Deepak L. Bhatt,Adrian F. Hernandez
摘要
Empagliflozin improves cardiovascular outcomes in patients with heart failure, patients with type 2 diabetes who are at high cardiovascular risk, and patients with chronic kidney disease. The safety and efficacy of empagliflozin in patients who have had acute myocardial infarction are unknown.
JY
寻道图强
lin
Cloud
CipherSage
穆紫
美好乐松
凤凰
星辰大海
温暖的盼山
hzc
黑白
脑洞疼
Simon
结实的寄柔
可爱的函函
科目三
Owen
只谈风月
霉小欧
皖公网安备34019202002308
